Edition:
United Kingdom

OncoMed Pharmaceuticals Inc (OMED.OQ)

OMED.OQ on NASDAQ Stock Exchange Global Select Market

2.87USD
19 Jan 2018
Change (% chg)

$-0.01 (-0.35%)
Prev Close
$2.88
Open
$2.86
Day's High
$3.01
Day's Low
$2.85
Volume
41,044
Avg. Vol
55,433
52-wk High
$10.86
52-wk Low
$2.85

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 6.20 -0.405
Mar '17 6.21 -0.607
FY 2016 Dec '16 6.22 -0.602
Sep '16 5.92 -0.766
Jun '16 6.66 -0.914
Mar '16 6.35 -0.900
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 2 5.60 6.20 5.00 5.28
Quarter Ending Jun-18 2 5.60 6.20 5.00 20.28
Year Ending Dec-18 6 24.48 37.70 18.00 45.94
Earnings (per share)
Quarter Ending Mar-18 2 -0.34 -0.27 -0.41 -0.95
Quarter Ending Jun-18 2 -0.34 -0.29 -0.40 -0.63
Year Ending Dec-18 6 -1.36 -1.10 -1.69 -2.49
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.70 32.90
P/E High - Last 5 Yrs. -- 302.09 46.03
P/E Low - Last 5 Yrs. -- 94.18 24.39
Beta 2.74 0.88 0.89
Price to Sales (TTM) 6.68 94.43 5.45
Price to Book (MRQ) -- 13.36 5.38
Price to Tangible Book (MRQ) -- 13.64 6.89
Price to Cash Flow (TTM) -- 72.87 23.43
% Owned Institutions 73.35 11.52 2.16

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.27 1.51
Dividend 5 Year Growth Rate -- 1.72 5.23
Payout Ratio(TTM) -- 16.22 43.58

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -7.07 401.22 9.01
Sales (TTM) vs TTM 1 Yr. Ago 0.01 71.05 5.44
Sales - 5 Yr. Growth Rate -4.35 33.10 10.34
EPS (MRQ) vs Qtr. 1 Yr. Ago 48.37 29.49 19.33
EPS (TTM) vs TTM 1 Yr. Ago 28.37 -- --
EPS - 5 Yr. Growth Rate -- 40.21 10.77
Capital Spending - 5 Yr. Growth Rate -12.42 40.33 15.26

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.77 2.18
Current Ratio (MRQ) 3.39 5.23 2.97
LT Debt to Equity (MRQ) -- 21.05 12.10
Total Debt to Equity (MRQ) -- 22.61 16.38
Interest Coverage (TTM) -- -102.06 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 41.21 54.76
Gross Margin - 5 Yr. Avg. -- 52.54 52.45
EBITD Margin (TTM) -335.43 -- --
EBITD - 5 Yr. Avg -181.75 -239.51 15.33
Operating Margin (TTM) -352.49 -519.41 7.60
Operating Margin - 5 Yr. Avg. -186.73 -256.70 10.79
Pre-Tax Margin (TTM) -350.45 -494.96 8.38
Pre-Tax Margin - 5 Yr. Avg. -186.42 -256.63 11.19
Net Profit Margin (TTM) -350.52 -496.46 4.70
Net Profit Margin - 5 Yr. Avg. -187.38 -259.85 7.50
Effective Tax Rate (TTM) -- 23.29 23.05
Effective Tax Rate - 5 Yr. Avg. -- 18.77 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 201,188 23,318,311 855,725,045
Net Income/Employee (TTM) -705,205 3,079,098 100,665,187
Receivable Turnover (TTM) 12.24 20.24 5.76
Inventory Turnover (TTM) -- 2.31 3.34
Asset Turnover (TTM) 0.15 0.39 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -53.56 0.09 10.97
Return on Assets - 5 Yr. Avg. -27.30 0.51 12.39
Return on Investment (TTM) -75.79 3.19 14.40
Return on Investment - 5 Yr. Avg. -34.15 3.64 16.20
Return on Equity (TTM) -- 4.52 16.09
Return on Equity - 5 Yr. Avg. -- 8.98 17.53
  1 Year 3 Year 5 Year
Sales % -2.88 -12.68 -4.35
EPS (TTM) % -10.32 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for OncoMed Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -3.11 -6.45 30 48
13 Week 27.49 21.28 82 60
26 Week -50.23 -54.01 10 70
52 Week -61.28 -67.18 12 47
YTD -43.45 -50.34 14 51
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 76.72%
# of Holders: 79
Total Shares Held: 29,043,282
3 Mo. Net Change: 1,380,070
# New Positions: 0
# Closed Positions: 2
# Increased Positions: 2
# Reduced Positions: 4
# Net Buyers: -2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.